Biphasic regulation of plasminogen activator/inhibitor by LDL in mesangial cells.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  AJP - Renal Physiology

• Publication date

  2002-09-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1152/AJPRENAL.00304.2001PMID 12167592
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Advanced glycosylation end products stimulate collagen mRNA synthesis in mesangial cells mediated by protein kinase C and transforming growth factor-beta.

  2001cited by this paper
• mRNA expression of urokinase and plasminogen activator inhibitor‐1 in human crescentic glomerulonephritis

  2001cited by this paper
• Induction of metalloproteinases by glomerular mesangial cells stimulated by proteins of the extracellular matrix.

  2001cited by this paper
• Plasminogen activator inhibitor type 1 is a potential target in renal fibrogenesis.

  2000influential reference
• LDL stimulates collagen mRNA synthesis in mesangial cells through induction of PKC and TGF-β expression.

  1999cited by this paper
• Oxidized LDL and lysophosphatidylcholine stimulate plasminogen activator inhibitor-1 expression in vascular smooth muscle cells.

  1999cited by this paper
• Fibrin zymography: a direct analysis of fibrinolytic enzymes on gels.

  1998cited by this paper
• Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration.

  1997cited by this paper
• Plasminogen and Plasminogen Activators Protect against Renal Injury in Crescentic Glomerulonephritis

  1997cited by this paper
• Involvement of oxidation in LDL-induced collagen gene regulation in mesangial cells.

  1996cited by this paper
• Dynamics of matrix turnover during pathologic remodeling of the extracellular matrix.

  1996cited by this paper
• Protein kinase C and lipid signaling for sustained cellular responses

  1995cited by this paper
• ECM degradation by cultured human mesangial cells is mediated by a PA/plasmin/MMP-2 cascade.

  1995cited by this paper
• Lipids and the kidney.

  1994cited by this paper
• Visualization of binding and uptake of oxidized low density lipoproteins by cultured mesangial cells.

  1994cited by this paper
• Heparin selectively inhibits synthesis of tissue type plasminogen activator and matrix deposition of plasminogen activator inhibitor 1 by human mesangial cells.

  1994cited by this paper
• Two-chain urokinase, receptor, and type 1 inhibitor in cultured human mesangial cells.

  1993cited by this paper
• Oxidized low density lipoproteins stimulate phosphoinositide turnover in cultured vascular smooth muscle cells.

  1992cited by this paper
• Physiological mechanisms for metalloproteinase activation.

  1992cited by this paper
• Plasminogen activator inhibitor-1 deposition in the extracellular matrix of cultured human mesangial cells.

  1992cited by this paper
• Role of plasmin and gelatinase in extracellular matrix degradation by cultured rat mesangial cells.

  1992cited by this paper
• Cell-specific regulation of plasminogen activator inhibitor 1 and tissue type plasminogen activator release by human kidney mesangial cells.

  1992cited by this paper
• Lipids and progressive kidney disease.

  1991cited by this paper
• Plasminogen activator inhibitor 1 in renal fibrin deposits of human nephropathies.

  1990cited by this paper
• The majority of type 1 plasminogen activator inhibitor associated with cultured human endothelial cells is located under the cells and is accessible to solution-phase tissue-type plasminogen activator

  1990cited by this paper
• Characterization of a plasminogen activator and its inhibitor in human mesangial cells.

  1989cited by this paper
• Amiloride selectively inhibits the urokinase‐type plasminogen activator

  1987cited by this paper
• Plasminogen activator inhibitors.

  1987cited by this paper
• The human tissue plasminogen activator gene.

  1986cited by this paper
• Cloning and sequence of a cDNA coding for the human beta-migrating endothelial-cell-type plasminogen activator inhibitor.

  1986cited by this paper
• Identification and primary sequence of an unspliced human urokinase poly(A)+ RNA.

  1984cited by this paper
• Substrate-attached membranes of cultured cells isolation and characterization of ventral cell membranes and the associated cytoskeleton.

  1981cited by this paper
• Cloning and sequence of a cDNA coding for the human a-migrating endothelial-cell-type plasminogen activator inhibitor

  year unknowncited by this paper

• Effect of Chenodeoxycholic Acid on Fibrosis, Inflammation and Oxidative Stress in Kidney in High-Fructose-Fed Wistar Rats

  2012cites this paper
• Effect of obesity on TAFI in postmenopausal period.

  2010cites this paper
• MOLECULAR MECHANISMS FOR REGULATION OF GENE EXPRESSION BY LYSOPHOSPHATIDIC ACID IN OVARIAN CARCINOMA CELLS

  2009cites this paper
• Increased renal collagen cross‐linking and lipid accumulation in nephropathy of Zucker diabetic fatty rats

  2008cites this paper
• Oxidized Low-Density Lipoprotein and Oxidative Stress in the Development of Glomerulosclerosis

  2008cites this paper
• Lovastatin inhibits oxidized low-density lipoprotein-induced plasminogen activator inhibitor and transforming growth factor-beta1 expression via a decrease in Ras/extracellular signal-regulated kinase activity in mesangial cells.

  2008cites this paper
• Role of CAGA boxes in the plasminogen activator inhibitor-1 promoter in mediating oxidized low-density lipoprotein-induced transcriptional activation in mesangial cells.

  2007cites this paper
• ERK contributes to the effects of Smad signaling on oxidized LDL‐induced PAI‐1 experssion in human mesangial cells

  2006cites this paper
• Low-Denisty Lipoprotein and Glomerulosclerosis

  2005cites this paper
• Regulation of renal lipid metabolism, lipid accumulation, and glomerulosclerosis in FVBdb/db mice with type 2 diabetes.

  2005influential citation
• Calorie restriction modulates renal expression of sterol regulatory element binding proteins, lipid accumulation, and age-related renal disease.

  2005cites this paper
• Oxidized LDL activates PAI-1 transcription through autocrine activation of TGF-beta signaling in mesangial cells.

  2005influential citation
• Role of altered renal lipid metabolism and the sterol regulatory element binding proteins in the pathogenesis of age-related renal disease.

  2005cites this paper
• Regulation The Expression Of Plasminogen Activator And Interluekin-6 In Women Plasma By Vitamin E After Abdominal Gynecological Operation

  2004cites this paper
• Glycated albumin activates PAI-1 transcription through Smad DNA binding sites in mesangial cells.

  2004cites this paper
• Angiotensin II mediates LDL-induced superoxide generation in mesangial cells.

  2003cites this paper